The Story of Lana Clayton

The Story of Lana Clayton

@Darkphoenix obviously #criminalization is a problem with any #drugs, thus destroying any #QualityControl and #ConsumerProtection a legal market has.
I'm not even shure a #drug like "#Flash" that is effective when administered as #EyeDrops would make sense.
Eye Drops Offer Non-Surgical Alternative for Age-Related Vision Loss
As people age, many experience presbyopia, a condition that makes it difficult to read up close. Traditionally, reading glasses have been the go-to solution, but new research presents a potentially better option: eye drops. In a study conducted on 766 patients, researchers tested a combination of pi... [More info]
Eyedrop chat (game-changer for getting them in!)
I've just gone back on drops, but I am truly shite at getting them in. Like, wasting 3-4 drops every time, multiple times a day.
This week I've been trying a 'Magic Touch' drop helper, where you put the drop on a thimble-like thing on top of your finger and then just pop it in.
And ohmygod it's actually fantastic. Like, it works every freaking time. So yeah, if you are also shite at drops then I recommend.
“The affected Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count is limited to lot number 10101, expiration date 2025/09. The product can be identified by the green and pink carton design, presence of “Systane” and “ULTRA PF” brand names on the front of the carton, and the “25 vials” package size”
“The FDA announced that Alcon Laboratories was voluntarily recalling one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go following a consumer complaint of ‘foreign material observed inside a sealed single use vial.’ Alcon determined the material to be "fungal in nature," according to the recall alert.”
https://www.localmemphis.com/article/news/nation-world/eye-drop-recall-systane-lubricant-eye-drops-ultra-pf/507-2c4a31e7-bf48-41a4-bc40-974753c06a0a
#eyeDrops #systane #recall
Breakthrough in Presbyopia Treatment: Entod Pharmaceuticals' PresVu Eye Drops Approved by DCGI
#peopletalky #health #bpresbyopia #eyedrops #presvu #healthnews
Entode Pharmaceuticals' innovative 'PresVu Eye Drops' has been approved by the DCGI, marking a significant advancement in presbyopia treatment. This solution offers rapid near vision improvement, long-term effects, and eye lubrication, presenting a non-invasive alternative to traditional treatments. With competitive pricing and patent pending, it promises to enhance the quality of life for presbyopia patients.